There are 133 resources available
Evaluating age as a factor for survival and quality of life in patients with BRAF V600E-mutant metastatic colorectal cancer treated with encorafenib + cetuximab ± binimetinib: subanalysis of BEACON CRC
Presenter: Kimmie Ng, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Clinical efficacy and single cell analysis of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients
Presenter: Ryan Corcoran, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Association of MSS/MSI-RNF43 molecular subtypes and clinical outcome of metastatic BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR ± combinatorial therapies
Presenter: Rodrigo Toledo, Spain
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Talks on Checkpoint Inhibitors in MSI-H Colorectal Cancer
Presenter: Thierry André, France
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
How to Make MSS Tumors More Sensitive for Immunotherapy
Presenter: Ryan Corcoran, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
BRAF Mutant Tumors: Strategy and New Data
Presenter: Scott Kopetz, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
MOUNTAINEER: Open-label, phase 2 study of tucatinib in combination with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017)
Presenter: Jonathan Strickler, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated colorectal cancer: Exploratory plasma biomarker analysis of CodeBreaK 100
Presenter: Hans Prenen, Belgium
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Rare Genomic Alterations Including Mutations and Fusions and Discussant
Presenter: Heinz-Josef Lenz, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Measurement of circulating tumor DNA (ctDNA) in appendiceal adenocarcinoma (AA): prevalence, predictors, and correlation with clinical outcome
Presenter: Mohammad Zeineddine, United States
Session: Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
Resources:
Slides